Cellex Overview

Founded 2002
Status Private
Employees 3
Latest Deal Type Grant
Latest Deal Amount $2.27M
Latest Deal Amount
Investors 1

Cellex General Information


Provider of medical diagnostic tests. The company offers two versions of a real-time Neuraminidase Inhibitor assay, which is designed for influenza diagnosis and drug resistance detection.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Primary Office
  • 9700 Great Seneca Highway
  • Rockville, MD 20850
  • United States
+1 (301) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 01-Mar-2011 $2.27M 00000 Completed Generating Revenue
4. Accelerator/Incubator 12-Aug-2010 00000 00000 Completed Generating Revenue
3. Accelerator/Incubator 06-Feb-2009 00000 00000 Completed Generating Revenue
2. Grant 15-Aug-2008 $964K Completed Generating Revenue
1. Grant 01-May-2005 $1.49M Completed Startup

Cellex Executive Team (1)

Name Title Board Seat Contact Info
James Li Ph.D Chief Executive Officer

Cellex Investors (1)

To view Cellex‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Maryland Industrial Partnerships Accelerator/Incubator Minority 000 0000 000000 0

Ready to get started?

Request a free trial